Masimo Return on Tangible Equity 2010-2025 | MASI
Current and historical return on tangible equity values for Masimo (MASI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Masimo Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.50B | $0.79B | -65.48% |
| 2024-12-31 | $-0.31B | $0.89B | -42.69% |
| 2024-09-30 | $0.08B | $0.69B | 12.27% |
| 2024-06-30 | $0.08B | $0.65B | 13.16% |
| 2024-03-31 | $0.08B | $0.62B | 13.66% |
| 2023-12-31 | $0.08B | $0.61B | 14.41% |
| 2023-09-30 | $0.09B | $0.55B | 16.20% |
| 2023-06-30 | $0.12B | $0.56B | 21.96% |
| 2023-03-31 | $0.12B | $0.56B | 23.80% |
| 2022-12-31 | $0.14B | $0.53B | 20.30% |
| 2022-09-30 | $0.17B | $0.47B | 18.40% |
| 2022-06-30 | $0.19B | $0.43B | 16.81% |
| 2022-03-31 | $0.22B | $1.41B | 16.74% |
| 2021-12-31 | $0.23B | $1.41B | 18.06% |
| 2021-09-30 | $0.23B | $1.29B | 18.97% |
| 2021-06-30 | $0.22B | $1.21B | 18.30% |
| 2021-03-31 | $0.23B | $1.15B | 18.81% |
| 2020-12-31 | $0.24B | $1.23B | 19.72% |
| 2020-09-30 | $0.22B | $1.28B | 18.68% |
| 2020-06-30 | $0.22B | $1.21B | 19.57% |
| 2020-03-31 | $0.21B | $1.15B | 19.54% |
| 2019-12-31 | $0.20B | $1.12B | 19.02% |
| 2019-09-30 | $0.19B | $1.06B | 19.38% |
| 2019-06-30 | $0.20B | $0.99B | 21.27% |
| 2019-03-31 | $0.20B | $0.96B | 22.45% |
| 2018-12-31 | $0.19B | $0.92B | 23.72% |
| 2018-09-30 | $0.14B | $0.86B | 18.35% |
| 2018-06-30 | $0.12B | $0.78B | 16.63% |
| 2018-03-31 | $0.12B | $0.72B | 17.48% |
| 2017-12-31 | $0.13B | $0.68B | 19.30% |
| 2017-09-30 | $0.36B | $0.67B | 59.19% |
| 2017-06-30 | $0.35B | $0.66B | 68.82% |
| 2017-03-31 | $0.34B | $0.59B | 82.66% |
| 2016-12-31 | $0.31B | $0.51B | 99.13% |
| 2016-09-30 | $0.11B | $0.28B | 45.08% |
| 2016-06-30 | $0.10B | $0.25B | 44.25% |
| 2016-03-31 | $0.09B | $0.22B | 39.91% |
| 2015-12-31 | $0.08B | $0.23B | 34.55% |
| 2015-09-30 | $0.08B | $0.22B | 32.26% |
| 2015-06-30 | $0.08B | $0.24B | 30.22% |
| 2015-03-31 | $0.07B | $0.28B | 27.33% |
| 2014-12-31 | $0.07B | $0.26B | 27.44% |
| 2014-09-30 | $0.06B | $0.23B | 22.57% |
| 2014-06-30 | $0.06B | $0.27B | 22.34% |
| 2014-03-31 | $0.07B | $0.30B | 23.99% |
| 2013-12-31 | $0.06B | $0.28B | 22.92% |
| 2013-09-30 | $0.06B | $0.26B | 26.64% |
| 2013-06-30 | $0.06B | $0.24B | 25.78% |
| 2013-03-31 | $0.06B | $0.23B | 25.30% |
| 2012-12-31 | $0.06B | $0.23B | 24.56% |
| 2012-09-30 | $0.06B | $0.26B | 23.20% |
| 2012-06-30 | $0.06B | $0.28B | 23.10% |
| 2012-03-31 | $0.06B | $0.26B | 22.90% |
| 2011-12-31 | $0.06B | $0.27B | 23.99% |
| 2011-09-30 | $0.07B | $0.29B | 25.93% |
| 2011-06-30 | $0.07B | $0.27B | 27.66% |
| 2011-03-31 | $0.06B | $0.24B | 27.92% |
| 2010-12-31 | $0.07B | $0.22B | 33.49% |
| 2010-09-30 | $0.07B | $0.24B | 30.47% |
| 2010-06-30 | $0.07B | $0.22B | 28.39% |
| 2010-03-31 | $0.07B | $0.20B | 27.15% |
| 2009-12-31 | $0.05B | $0.28B | 20.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.740B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.575B | 80.40 |
| Thermo Fisher Scientific (TMO) | United States | $152.039B | 18.39 |
| Edwards Lifesciences (EW) | United States | $44.083B | 28.90 |
| Alcon (ALC) | Switzerland | $42.518B | 28.73 |
| IDEXX Laboratories (IDXX) | United States | $42.037B | 48.31 |
| DexCom (DXCM) | United States | $32.149B | 49.69 |
| IQVIA Holdings (IQV) | United States | $27.142B | 15.20 |
| Mettler-Toledo (MTD) | United States | $24.013B | 28.56 |
| STERIS (STE) | Ireland | $23.741B | 26.15 |
| Waters (WAT) | United States | $20.370B | 28.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.723B | 0.00 |
| Hologic (HOLX) | United States | $14.429B | 15.68 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $9.933B | 77.96 |
| Globus Medical (GMED) | United States | $7.974B | 19.00 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.75 |
| TransMedics (TMDX) | United States | $4.833B | 105.06 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.355B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.86 |
| Nihon Kohden (NHNKY) | Japan | $2.264B | 25.96 |
| Veracyte (VCYT) | United States | $2.071B | 29.06 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.617B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.383B | 0.00 |
| Artivion (AORT) | United States | $1.206B | 113.00 |
| Pulse Biosciences (PLSE) | United States | $1.061B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.945B | 5.02 |
| Beta Bionics (BBNX) | United States | $0.828B | 0.00 |
| SiBone (SIBN) | United States | $0.742B | 0.00 |
| IRadimed (IRMD) | United States | $0.740B | 37.53 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.70 |
| Delcath Systems (DCTH) | United States | $0.534B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 12.42 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| AxoGen (AXGN) | United States | $0.444B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.433B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.431B | 0.00 |
| NeuroPace (NPCE) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.357B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.330B | 8.78 |
| ClearPoint Neuro (CLPT) | United States | $0.323B | 0.00 |
| 908 Devices (MASS) | United States | $0.262B | 0.00 |
| Neuronetics (STIM) | United States | $0.249B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.183B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.10 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.35 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |